Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors

• Päätekijät: Jianing Chen (Tekijä), Yaokai Wen (Tekijä), Xiangling Chu (Tekijä), Yuzhi Liu (Tekijä), Chunxia Su (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Introduction: Non-small cell lung cancer patients have gained therapeutic benefits from immune checkpoint inhibitors, although immune-related adverse events (irAEs) could be inevitable. Whether irAEs are associated with chronic diseases is still unclear, our study aims to clarify the distinct advers...